The baseline recurrence risk of patients with intermediate-risk cervical cancer.

ABSTRACT:

Objective

This study aimed to investigate the prognosis of patients with intermediate-risk cervical cancer and to evaluate the necessity of adjuvant therapy.

Methods

We conducted a retrospective chart review of patients with stage IB-II cervical cancer who underwent type III radical hysterectomy with pelvic lymphadenectomy between 2008 and 2017. In our institution, radical hysterectomy is performed as an open surgery and not as a minimally invasive surgery, and adjuvant therapy is not administered to patients with intermediate-risk cervical cancer. The intermediate-risk group included patients with 2 or more of the following factors: tumor size >4 cm, stromal invasion >1/2, and lymphovascular stromal invasion. Intermediaterisk patients with squamous cell carcinoma were inclu

SUBMITTER: Yoneoka Y 

PROVIDER: S-EPMC7991004 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature